Divi's Laboratories stock

DIVISLAB · NSE · INR

Compare Divi's Laboratories
₹11,180.50Change from previous close: +0.02%Absolute change: +₹2.50

Close · November 20, 2026

Price history

+73.01% over the period

1 year: from ₹6,462.50 (November 20, 2025) to ₹11,180.50 (November 20, 2026), +73.01%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026₹11,180.50
October 30, 2026₹9,780.00
September 30, 2026₹9,291.50
August 31, 2026₹9,467.00
July 31, 2026₹8,056.00
June 30, 2026₹6,579.00
May 29, 2026₹6,667.00
April 30, 2026₹6,502.50
March 30, 2026₹5,947.00
February 27, 2026₹6,408.50
January 30, 2026₹6,051.00
December 31, 2025₹6,392.50
November 28, 2025₹6,477.00
November 20, 2025₹6,462.50

At a glance

  • The company

    Manufacture and sale of generic active pharmaceutical ingredients, intermediates, nutraceuticals and carotenoids for pharmaceutical, food and beverage industries

  • Latest results

    Quarter to September 30, 2026 · EPS ₹42.49 (estimate ₹32.10)

TickerLandia's take on Divi's Laboratories

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low₹5,647.50
52-wk high₹11,824.00

−5.44% from the 52-week high

Analysts · 28 analysts

Average target₹11,163.39−0.15% vs. price

Buy 18 · Hold 5 · Sell 5 · Buy

TickerLandia Fingerprint: Divi's Laboratories

Compared with similar companies: very strong momentum, very high price, and very high financial strength.

Financials and price compared with 39 companies in the drug manufacturers - specialty & generic industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Divi's Laboratories is pricier than in the past and pricier than similar companies

On the latest fiscal year's earnings (2026), Divi's Laboratories's P/E today is 115.6, above the median of its last 10 fiscal years (40.3; between 15.6 and 70.0 from 2017 to 2026). Divi's Laboratories's P/E (trailing 12 months): 88.2, +114% against the median of a group of 11 similar companies (41.2).

P/E compared with its history

Compared with 11 similar companies

Divi's Laboratories's metrics compared with similar companies
MetricDivi's LaboratoriesPosition in the groupBand
P/E (trailing 12 months)88.2High
Forward P/E63.3High
Operating margin34.0%High
ROE20.1%High
Debt/equity0.00Low

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Divi's Laboratories. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

₹36.76B

Latest quarter · Q3 2026

Net income

₹11.27B

Latest quarter · Q3 2026

Quarterly net margin

30.7%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
₹2.97T
P/E
88.2
EPS
₹126.72
Volume
404.83K
Daily trading
€86.81M
Dividend yield
0.27%
Last ex-dividend on July 24, 2026

How Divi's Laboratories is changing

All results
  • Revenue grew 8.7% a year on average over the last 5 years

  • Operating margin rose from 26.1% to 28.2%

  • Less cash than profit: free cash flow equal to 11% of net income

Returns

Divi's Laboratories returns with dividends

₹1,000 invested in Divi's Laboratories 5 years ago, on November 22, 2021, would be worth ₹2,463 today with dividends reinvested: +146.30% in total, +19.78% per year. On price alone it would be ₹2,389 (+138.94%).

PeriodDivi's Laboratories₹1,000 becomes
1 month+21.66%₹1,217
6 months+62.20%₹1,622
Year to date+74.90%₹1,749
1 year+73.72%₹1,737
3 years+208.89%₹3,089
5 years+146.30%₹2,463
10 years+926.42%₹10,264

From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment

The chart in detail

Divi's Laboratories: technical analysis

Divi's Laboratories is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 3.3% below its all-time closing high (₹11,565.50, November 9, 2026).

Trend
Upward
RSI (14 sessions)
68
Between 30 and 70
vs 200-session average
+45.21%

Support and resistance

Price areas where Divi's Laboratories has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. No resistance above: the price is near the highs of the year
  2. Last price₹11,180.50
  3. Support₹9,580.67−14.31%3 touches, last on October 7, 2026
  4. Support₹8,979.50−19.69%3 touches, last on October 14, 2026
  5. Support₹8,735.50−21.87%2 touches, last on October 23, 2026

Volatility and risk

Volatility (60 sessions, annualised)
30.3%
Largest fall in the last year
−12.37%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Divi's Laboratories: seasonality

Average monthly price change over 24 years

−5.6%Jan−0.1%Feb+0.4%Mar+7.5%Apr+3.6%May+3.5%Jun+6.3%Jul+5.9%Aug+3.4%Sep+3.0%Oct+4.4%Nov+4.0%Dec

Over the last 24 years, the strongest month for Divi's Laboratories has been April: +7.50% on average, positive in 20 years out of 24. The weakest has been January: −5.61% on average, positive in 7 years out of 23. November, the current month, has been positive in 12 years out of 23 (+4.39% on average).

Show chart data
MonthAverageMedianPositive years
January−5.61%−4.91%7 of 23
February−0.14%−1.75%9 of 23
March+0.38%+3.21%13 of 23
April+7.50%+6.02%20 of 24
May+3.55%+3.92%15 of 24
June+3.54%+1.44%16 of 24
July+6.25%+4.90%19 of 24
August+5.90%+5.73%16 of 24
September+3.38%+0.98%14 of 24
October+3.02%+3.31%16 of 24
November+4.39%+1.77%12 of 23
December+4.03%+3.34%17 of 23

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Divi's Laboratories and its competitors

Clients in North America, Europe, Asia and India, along with other international buyers, make up the markets Divi's Laboratories serves. The company manufactures and sells generic active pharmaceutical ingredients, chemical intermediates and nutraceuticals, and it also provides custom synthesis and contract manufacturing for APIs and intermediates. Its carotenoid line includes astaxanthin, beta-carotene and lycopene, alongside vitamins supplied to producers of food, supplements and animal feed. It also exports its products.

Headquarters
Hyderabad, India
Employees
11,565
Founded
1990
Chief executive
Kiran Divi
Divi's Laboratories and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Divi's LaboratoriesDIVISLAB$32.03B34.0%88.2+62.20%
Hansoh Pharmaceutical Group3692$23.77B37.3%25.0−8.51%
Jiangsu Hengrui Pharmaceuticals600276$46.71B27.4%35.1−7.75%
Sun Pharmaceutical IndustriesSUNPHARMA$48.8B23.3%41.2+0.24%
Torrent PharmaceuticalsTORNTPHARM$19.25B22.2%79.2+5.88%
Shionogi4507$16.75B31.6%11.2+2.83%

Same industry or related industries, similar size. Compare Divi's Laboratories with its competitors · Full profile